BioCorRx (BICX) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.02% |
| Dec 31, 2025 | -37.15% |
| Sep 30, 2025 | 351.71% |
| Jun 30, 2025 | -224.13% |
| Mar 31, 2025 | -16.79% |
| Dec 31, 2024 | -66.37% |
| Sep 30, 2024 | 39.64% |
| Jun 30, 2024 | 52.39% |
| Mar 31, 2024 | 30.10% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | -53.47% |
| Jun 30, 2023 | -40.15% |
| Mar 31, 2023 | 0.51% |
| Dec 31, 2022 | 4.81% |
| Sep 30, 2022 | 78.49% |
| Jun 30, 2022 | 71.76% |
| Mar 31, 2022 | 83.64% |
| Dec 31, 2021 | 71.21% |
| Sep 30, 2021 | 17.80% |
| Jun 30, 2021 | 47.43% |
| Mar 31, 2021 | 49.22% |
| Dec 31, 2020 | 74.06% |
| Sep 30, 2020 | 71.38% |
| Jun 30, 2020 | 68.08% |
| Mar 31, 2020 | -1,155.26% |
| Dec 31, 2019 | -674.15% |
| Sep 30, 2019 | -1,374.13% |
| Jun 30, 2019 | -746.82% |
| Mar 31, 2019 | -17,492.03% |
| Dec 31, 2018 | -3,005.79% |
| Sep 30, 2018 | 12.27% |
| Jun 30, 2018 | 31.71% |
| Mar 31, 2018 | 99.89% |
| Dec 31, 2017 | 92.04% |
| Sep 30, 2017 | -251.68% |
| Jun 30, 2017 | 28.07% |
| Mar 31, 2017 | -1,282.85% |
| Dec 31, 2016 | 35.27% |
| Sep 30, 2016 | -830.04% |
| Jun 30, 2016 | -818.89% |
| Mar 31, 2016 | -468.89% |
| Dec 31, 2015 | -314.27% |
| Sep 30, 2015 | -8.11% |
| Jun 30, 2015 | 60.16% |
| Mar 31, 2015 | 83.40% |
| Dec 31, 2014 | 51.07% |
| Dec 31, 2013 | -1,708.83% |
| Dec 31, 2012 | -262.22% |
| Dec 31, 2011 | 76.75% |